Skip to content

The effect of ropivacaine combined with dexamethasone erector spinae plane block on the incidence of postoperative chronic pain in patients undergoing thoracoscopic lobectomy

The effect of ropivacaine combined with dexamethasone erector spinae plane block on the incidence of postoperative chronic pain in patients undergoing thoracoscopic lobectomy

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400087769
Enrollment
Unknown
Registered
2024-08-05
Start date
2024-08-08
Completion date
Unknown
Last updated
2024-08-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lung tumors

Interventions

Experimental group:Single session erector spinae plane block guided by ultrasound using a mixture of 5mg dexamethasone and 30ml 0.5% ropivacaine
Control group:Ultrasound guided erector spinae plane block with 30ml of 0.5% ropivacaine

Sponsors

The Second People's Hospital of Yibin
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1.Patients undergoing thoracoscopic lobectomy under elective general anesthesia 2.Age 18-75 years old, BMI 18-24 kg/m2 3.ASA classification: Grade I-III 4.No serious organ disease, such as heart, liver and kidney damage, no history of blood disease, diabetes, mental illness and other related diseases, no serious visual or hearing impairment, and can communicate effectively with doctors

Exclusion criteria

Exclusion criteria: 1.Individuals with a history of mental and neurological disorders, long-term alcohol and drug abuse, and long-term use of analgesic drugs 2.Preoperative determination of cognitive impairment in patients 3.Withdrawing from the experimenter due to personal reasons 4.Those who cannot cooperate due to other reasons 5.Patients who are allergic to or have adverse reactions to the anesthesia drugs used 6.Patients with infection at the puncture site and coagulation dysfunction

Design outcomes

Primary

MeasureTime frame
Incidence of chronic pain;

Secondary

MeasureTime frame
Rest and cough VAS pain scores at 1, 6, 12, 24, and 48 hours postoperatively;Bruggrmann comfort scale;Dosage of intravenous anesthetics;Perioperative use of vasoactive drugs;Number of cases of tramadol salvage analgesia;

Countries

China

Contacts

Public ContactZhang Chaogui; Wang Changsong

The Second People's Hospital of Yibin

190808643@qq.com+86 137 0829 0804

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026